The enforcement scale is real: more than 455 FDA adverse-event reports tied to compounded semaglutide, over 50 warning letters to compounded GLP-1 sellers in 2025, and 30-plus more in March 2026, several of them naming the compounding pharmacies behind telehealth brands
Patients with a history of gastrointestinal conditions such as acid reflux, irritable bowel syndrome, or gastroparesis should be especially cautious when starting GLP-1 medications
Fortino and his staff of well trained nurse practitioners to determine if combining these weight loss treatments are right for you and to ensure your health and safety
Phillips Aesthetics, our goal is to empower you with the tools and treatments you need to achieve your best health and appearance
Current peer-reviewed research and FDA clinical data show no proven direct link between Ozempic and the development of atrial fibrillation
Wegovy contains a higher dose of semaglutide (1.7 mg or 2.4 mg per week) versus Ozempic (2 mg per week)